Delivery Order SPE2DB20D3103-SPE2DB25FP6Y5
- Not listed
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $6,535.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $81,411.49 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed price contract. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $32,675.40 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,605.24 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,151.86 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded without set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,795.15 to supply Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine product, with a completion date of July 21, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs, with performance conducted at the contractor's facility in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,337.95 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringe format. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a $9,187.28 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5 mL) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's facility...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6Y5Delivery Order
The Defense Logistics Agency awarded a $31,991.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) with an ultimate completion date of July 31, 2025. This non-set-aside competitive award was issued on July 30, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical supplier for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies. This delivery order for the pneumococcal vaccine Prevnar 20 supports DLA's medical supply chain requirements and aligns with the company's extensive track record of fulfilling federal procurement needs across multiple therapeutic domains. The competitive award reflects AmerisourceBergen's demonstrated capability to meet federal requirements and its role as a strategic partner in supporting Defense Health Agency operations and broader government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 7/30/25 |